1.14

9.62% 0.10

Lite Strategy Inc (LITS)

Overview News Price History Discussions Forecast

Lite Strategy Inc stock is traded at $1.14, with a volume of 158.09K. It is up +9.62% in the last 24 hours and up +20.72% over the past month. Lite Strategy Inc is focused on the clinical development of novel therapies for cancer. The company's portfolio of drug candidates includes voruciclib, an oral cyclin-dependent kinase 9 (CDK9) inhibitor and zandelisib, an oral, once-daily, selective PI3K inhibitor. It is a clinical-stage pharmaceutical company committed to the development of novel and differentiated cancer therapies intended to improve outcomes for patients.

Previous Close:

$1.04

Open:

$1.02

24h Volume:

158.09K

Relative Volume:

0.52

Market Cap:

$38.79M

Revenue:

$65.30M

Net Income/Loss:

$-60.82M

P/E Ratio:

-0.5659

EPS:

-2.0145

Net Cash Flow:

$-110.42M

1W Performance:

+16.28%

1M Performance:

+20.72%

6M Performance:

-6.56%

1Y Performance:

+0.00%

1-Day Range:

$1.02

$1.14

1-Week Range:

$0.9601

$1.14

52-Week Range:

$0.6888

$3.03

Lite Strategy Inc Stock (LITS) Company Profile

Name

Lite Strategy Inc

Sector

Healthcare (1074)

Industry

Biotechnology (600)

Phone

858-369-7100

Address

9920 PACIFIC HEIGHTS BLVD, SAN DIEGO

Employee

Twitter

Next Earnings Date

2026-09-25

Latest SEC Filings

LITS's Discussions on Twitter

Compare LITS vs VRTX, REGN, ARGX, MRNA, RVMD

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
LITS Lite Strategy Inc	1.14	32.10M	65.30M	-60.82M	-110.42M	-2.0145
VRTX Vertex Pharmaceuticals Inc	546.12	136.93B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	827.72	85.11B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	1,033.15	64.95B	4.16B	1.29B	734.26M	19.58
MRNA Moderna Inc	145.55	53.23B	2.23B	-3.19B	-1.60B	-8.1462
RVMD Revolution Medicines Inc	210.02	45.38B	742.00K	-1.37B	-1.07B	-7.0731

Lite Strategy Inc Stock (LITS) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jul-23-24	Downgrade	Laidlaw	Buy → Hold
Mar-25-22	Downgrade	Jefferies	Buy → Hold
Mar-25-22	Downgrade	Stifel	Buy → Hold
Mar-25-22	Downgrade	Wells Fargo	Overweight → Equal Weight
Feb-03-22	Initiated	Jefferies	Buy
Sep-22-20	Initiated	Alliance Global Partners	Buy
May-29-20	Initiated	SunTrust	Buy
Dec-20-18	Initiated	H.C. Wainwright	Buy
Jul-27-18	Upgrade	Stifel	Hold → Buy
Jul-13-18	Initiated	SunTrust	Buy
Apr-18-16	Reiterated	Wedbush	Neutral
Mar-23-15	Downgrade	ROTH Capital	Buy → Neutral
Dec-18-14	Reiterated	ROTH Capital	Buy
Oct-16-14	Reiterated	ROTH Capital	Buy
Jul-08-14	Resumed	Brean Capital	Buy
Oct-22-13	Reiterated	Stifel	Buy
Apr-15-13	Initiated	Stifel	Buy

View All

Lite Strategy Inc Stock (LITS) Latest News

Aug 21, 2026

Omni-Lite Industries Canada Stock Climbs 9.06% as Record Performance and Aerospace-Defense Demand Strengthen Momentum - kalkine.ca

Aug 21, 2026

Aug 20, 2026

Lite (LITS) Earnings Reading: EPS Does Not Reach the Reported Estimate; Post-Earnings: The Stock Records a 6.58% Increase in the Latest SessionEarnings Stability Report - vinanet.vn

Aug 20, 2026

Aug 19, 2026

KPTI Stock Price and Chart — NASDAQ:KPTI - TradingView

Aug 19, 2026

Omni-Lite Industries Stock Slides as Downside Pressure Builds: TSXV:OML Faces Correction Risk Despite Improving Fundamentals - kalkine.ca

Aug 19, 2026

Aug 18, 2026

The CLARITY Act won’t move markets. It will move people. - Cryptonews.net

Aug 18, 2026

Aug 17, 2026

Lite Strategy, Inc. (NASDAQ: LITS) Share Price, LITS Stock News, LITS Share Price & Updates - Kalkine

Aug 17, 2026

Aug 16, 2026

Lite Strategy (LITS) Slips 1.01% to $0.89 as It Tests Support ZoneBreakout Confirmation - Vinanet

Aug 16, 2026

Aug 14, 2026

Jim Cramer Weighs In on Lumentum (LITE) and Coherent (COHR) Post-Earnings - Yahoo Finance

Aug 14, 2026